This workshop is designed to inform clinicians about the many psychologically-pertinent issues related to legalized marijuana usage, including:
- What information must be provided to ensure clients are receiving quality information from a harm reduction, empirically validated position?
- How do we avoid the dichotomy of “it’s harmless” vs “it’s harmful and a gateway drug” that features in social conversations on marijuana?
- What do we, as treating clinicians, need to better understand and continually assess concerning clients’ choices concerning the use of marijuana?
- What is our role and obligation concerning due diligence and ethics?
- What concerns are particularly pertinent to the young (developing) brain?
- How might we work with clients to ensure open communication and strong therapeutic alliance while still providing necessary and accurate information?
These questions and more will be addressed in the morning overview, followed by detailed Q & A sessions in the afternoon.
Cost: $120 for OACCPP Members ($160 for Non-Members)
Date: June 8, 2019
Time: 8:30am – 4:00pm
Location: Tecumseh Auditorium, Oakham House
63 Gould Street Toronto M5B 1E9
Coffee, refreshments and lunch included.
Please note, space is limited.
OACCPP Members: Register from the OACCPP Member’s Portal
Non-Members: REGISTER HERE
About the Presenter:
Dr. David Teplin is a clinical psychologist in full-time private practice in Toronto. His primary clinical focus is clinical assessment, clinical consultation, adult ADHD, and substance use disorders. He is also an adjunct professor at Medaille College, in Buffalo, New York, where he teaches in the doctoral program in clinical psychology. He sits on the editorial review board of several peer-reviewed clinical journals and serves on professional advisory boards for adult ADHD. He was also the Chair of the Canadian Psychological Association task-force on the legalization of cannabis.